Royalty Report: Medical, Device, Therapeutic – Collection: 375

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 13

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 13

Primary Industries

  • Medical
  • Device
  • Therapeutic
  • cardiac
  • Supply
  • Nerve
  • Technical Know How
  • Electro Medical/ Elector therapeutic
  • Diagnostic
  • Drugs
  • Pharmaceuticals
  • Health & Fitness

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 375

License Grant
Licensor hereby grants to Licensee, and Licensee hereby accepts from Licensor, upon the terms and conditions herein after specified, the exclusive, worldwide right and license under the Licensed Patents and Technology to further test and develop the Technology, to make, to have made, to use, to sell, to lease, to implant, and to have implanted and otherwise dispose of Products and to sublicense the rights created hereby pursuant to the terms.
License Property
Technology relates to a patent for Neurocyberenetic Prosthesis Technology.  This license agreement covers the method and devices of the neurocybernetic prosthesis ('NCP') System for vagus nerve and other cranial nerve stimulation for the control of epilepsy and other movement disorders.  The NCP system is an implantable, multiprogrammable pulse generator that delivers constant current electrical signals to the vagus nerve for the purpose of reducing the frequency and severity of epileptic seizures. The signals are delivered on a predetermined schedule, or may be initiated by the patient with an external magnet. The device is implanted in a subcutaneous pocket in the chest just below the clavicle, similar to pacemaker placement. The stimulation signal is transmitted from the prosthesis to the vagus nerve through a lead connected to an electrode which is a multi-turn silicone helix, with a platinum band on the inner turn of one helix. The prosthesis can be programmed with any IBM- compatible personal computer using NCP software and a programming wand.

Licensor owns a patent relating to Neurocyberenetic Prosthesis Technology (U.S. Patent No. 4,702,254) and other pending patent applications and know-how, and technology relating thereto (collectively referred to as the “Technology”).

4,702,254

US

NeuroCybernetic Prosthesis

Oct. 27, 1987

4,867,164

US

NeuroCybernetic Prosthesis

Sept. 19, 1989

50,258,807

US

NeuroCybernetic Prosthesis

June 25, 1991

577,549

Australia

NeuroCybernetic Prosthesis

March 3, 1989
1,259,379

Canada

NeuroCybernetic Prosthesis

September 12, 1989
0,156,854

Eurpoean

NeuroCybernetic Prosthesis

September 5, 1990

Austria, Belgium, Switzerland, Germany, France, United

Kingdom, Liechtenstein, Luxembourg, Netherlands, Sweden

503,504/84

Japan

Application Number

September 11, 1984

Field of Use
NCP System is an implantable medical device for the treatment of epilepsy.

IPSCIO Record ID: 372635

License Grant
Licensor grants Licensee an exclusive worldwide license for the Field of Use under the Licensed Patents and Licensed Know-How to make, have made for, use, have used for, sell, have sold for, offer to sell, import and/or otherwise dispose of Products, to practice, have practiced for, teach and have taught for Licensed Methods, and to otherwise commercially exploit the Licensed Know-How and the technology disclosed in the Licensed Patents and Licensed Know-How.
License Property
“Licensed Patent(s)” are the Licensed Cyberonics Patent(s) and the Licensed Roslin Patents.

Cyberonics Patents
5,188,104  Treatment of Eating Disorders by Nerve Stimulation
5,231,988 Treatment of Endocrine Disorders by Nerve Stimulation
5,263,480 Treatment of Eating Disorders by Nerve Stimulation
5,540,730 Treatment of Motility Disorders by Nerve Stimulation
5,540,734 Cranial Nerve Stimulation Treatments Using Neurocybernetic Prosthesis
5,707,400 Treating Refractory Hypertension by Nerve Stimulation
20060247719 Weight Loss Method and Device
20060247721 Identification of Electrodes for Nerve Stimulation in the Treatment of Eating Disorders
20060247722 Noninvasively Adjustable Gastric Band
20070027483 Stimulating Cranial Nerve to Treat Disorders Associated with the Thyroid Gland
20070027484 Autonomic Nerve Stimulation to Treat a Pancreatic Disorder
20070027492 Autonomic Nerve Stimulation to Treat a Gastrointestinal Disorder
20070027498 Selective Nerve Stimulation for the Treatment of Eating Disorders
20070093870 Cranial Nerve Stimulation to Treat Eating Disorders

Roslin Patents
6,587,719  Treatment of Obesity by Bilateral Vagus Nerve Stimulation
6,609,025  Treatment of Obesity by Sub-Diaphragmatic Nerve Stimulation
7,299,091  Treatment of Obesity by Bilateral Vagus Nerve Stimulation
20040039427  Treatment of Obesity by Sub-Diaphragmatic Nerve Stimulation

Field of Use
Licensee has the rights to ther patents and patent applications to use vagus nerve stimulation for the treatment of obesity and two related co-morbidities, diabetes and hypertension, in overweight patients.

“Field of Use” shall mean the treatment (including therapeutic or diagnostic) by means of a device that applies electrical signals directly or indirectly to the vagus, trigeminal or glossopharyngeal nerves i) for weight reduction, or ii) for hypertension or diabetes (including impaired fasting glycaemia, impaired glucose tolerance or insulin resistance) in patients having a body mass index of 25 or more.

IPSCIO Record ID: 27339

License Grant
The Company executed a license agreement for a specific application of the patented Implantable Electrode Array to be used in the control of epilepsy and other movement disorders.

IPSCIO Record ID: 275818

License Grant
Licensor grants a non-transferable, exclusive, worldwide license or sublicense, under the Licensed Patents and Licensed Know-How, to practice and otherwise exploit the same in the Field only, to make, have made, use, sell, offer to sell, and/or import Licensed Products & Methods.
License Property
The property is certain technology to stimulate the vagus nerve.

The vagus nerve, historically cited as the pneumogastric nerve, is the tenth cranial nerve or CN X, and interfaces with the parasympathetic control of the heart, lungs, and digestive tract. The vagus nerves are paired but are normally referred to in the singular.

Licensed Patents means the NS, the Feinstein Institute for Medical Research, formerly known as North Shore Long Island Jewish Research Institute licensed Patents.

The patents include Inhibition of Inflammatory Cytokine Production by Stimulation of Brain Muscarinic Receptors, and, Cholinergic Agonists and Vagus Nerve Stimulation, and, Neural Tourniquet.

Field of Use
The Field means vagal nerve stimulation by any means. Exemplary vagal nerve stimulation modalities within the Field include mechanical (such as massage, needle, acoustic or other vibrational), electrical, thermal, magnetic, and electromagnetic, or as produced by any other energy source.

Vagus nerve stimulation is a medical treatment that involves delivering electrical impulses to the vagus nerve. It is used as an add-on treatment for certain types of intractable epilepsy and treatment-resistant depression. Frequent side effects include coughing and shortness of breath.

IPSCIO Record ID: 88532

License Grant
The Licensor hereby grants to the Licensee, and the Swiss Licensee hereby accepts, a non-exclusive, royalty-bearing right and license under the Licensed IP to use, make, have made, sell, offer to sell, distribute and import Licensed Products in the Territory during the Term for applications within the Field of Use; provided, however, that upon the occurrence of a License Conversion Event, the portion of the non-exclusive license consisting of the non-exclusive, royalty-bearing license to sell, offer to sell, distribute and import Licensed Products in the Territory during the Term for applications within the Field of Use (the Non-Exclusive Distribution License) shall immediately, and without the need for any action on the part of either party, convert into an exclusive, royalty-bearing license to sell, offer to sell, distribute and import Licensed Products in the Territory during the Term for applications within the Field of Use (Exclusive Distribution License); provided, however, that the exclusivity of such Exclusive Distribution License shall be subject to, and shall not impact, any license rights previously granted in favor of Greatbatch pursuant to the Greatbatch License Agreement; provided, further, however, that if the Licensee fails to obtain FDA Approval for the Licensed Products within six (6) years after the License Conversion Date, the Exclusive Distribution License shall become convertible by the Licensor, at its sole discretion, back into a Non-Exclusive Distribution License. For the avoidance of doubt, during the Term, the non-exclusive, royalty-bearing license to use, make and have made Licensed Products in the Territory during the Term for applications within the Field of Use shall continuously remain a non-exclusive license.  License Conversion Event means the first to occur of (i) receipt of a Conformité Européenne (CE) mark for the Licensed Products that permits sale of such Licensed Products within the European Economic Area for application within the Field of Use; (ii) receipt of FDA Approval or (iii) completion by the Licensee of a human clinical study demonstrating safety and efficacy required to obtain (A) a Conformité Européenne (CE) mark for the Licensed Products that permits sale of such Licensed Products within the European Economic Area for applications within the Field of Use, or (B) FDA Approval.
License Property
United States (U.S.) Licensed Patents
8,954,148  Key Fob controller for an implantable neurostimulator  
8,483,836  Automated search to identify a location for electrical stimulation to treat a patient
8,515,545  Current steering neurostimulator device with unidirectional current sources
8,571,667  Active current control using the enclosure of an implanted pulse generator
8,738,153  Implantable lead with braided conductors
8,757,485  System and method for using clinician programmer and clinician programming data for inventory and manufacturing prediction and control
8,761,892  Active current control using the enclosure of an implanted pulse generator
8,761,897  Method and system of graphical representation of lead connector block and implantable pulse generators on a clinician programmer
8,781,592  Identifying an area for electrical stimulation to treat a patient
8,812,125  Systems and methods for the identification and association of medical devices
8,868,199  System and method of compressing medical maps for pulse generator or database storage
8,874,219  Arbitrary waveform generator and neural stimulation application
8,903,496  Clinician programming system and method
8,983,616  Method and system for associating patient records with pulse generators
8,996,115  Charge balancing for arbitrary waveform generator and neural stimulation application
8,996,117  Arbitrary waveform generator and neural stimulation application with scalable waveform feature
8,700,175  Devices and methods for visually indicating the alignment of a transcutaneous energy transfer device over an implanted medical device
9,002,466  Diversity antennas for neurostimulator programming devices
9,031,664  Current steering neurostimulator device with unidirectional current sources
9,031,666  Devices and methods for visually indicating the alignment of a transcutaneous energy transfer device over an implanted medical device
9,067,074  Automated search to identify a location for electrical stimulation to treat a patient
9,072,903  System and method of establishing a protocol for providing electrical stimulation with a stimulation system to treat a patient
9,098,610  Communication for implantable medical devices
9,101,767  Measuring load impedance with active stimulation pulses in an mplanted pulse generator
9,126,043  Patient handheld device for use with a spinal cord stimulation system
D663,035  Two-port implantable medical device
D665,086  Three-port implantable medical device
D665,087  Multi-port implantable medical device
D671,900  Pocket controller for implantable neurostimulator
D698,779  Clinician programmer for implantable neurostimulator
Field of Use
Field of Use means deep brain stimulation for movement disorders (i.e. Parkinson’s disease and/or essential tremor).

IPSCIO Record ID: 250719

License Grant
Foundation hereby grants to Licensee royalty-bearing, license, with the right to sublicense to make, have made, lease, offer to lease, use, sell, offer for sale, market, promote, advertise, import, research, develop and commercialize Licensed Products in the Field only, in the Territory; provided that with respect to Externals, the foregoing license shall only apply to the extent that such Externals are used in connection with the foregoing licensed activities involving Licensed Products other than Externals.
License Property
“Licensed Product” means (i) Epione and (ii) all Externals sold or distributed solely for use with Epione.

Licensed Products are worldwide for the treatment of (i) chronic pain in humans through the application of electrical energy to the nervous system, (ii) inflammatory conditions of the human body through the application of electrical energy to the vagus nerve, a nerve that interfaces with parasympathetic control of the heart, lungs and digestive tract and (iii) urinary and fecal dysfunction in humans through the application of electrical energy anywhere in or on the human body, excluding, in each case, any product or method that involves the placement of electrodes or the administration of electrical stimulation inside the cranial cavity or to the ocular nervous system or the auditory nervous system.

“Epione” means the Epione implantable pulse generator, leads, external pulse generator, charging system and related system components and software

“Externals” means any peripheral or auxiliary device that can be used in connection with, or operate in concert with, Epione, including the components that when assembled comprise such device, and including surgical procedure tools, protection apparatus, controllers, battery chargers, patient remote controller, programmer, software and electrodes.

Field of Use
“Initial Field” means (i) the treatment of chronic pain in humans through the application of electrical energy to the nervous system; and (ii) the treatment of inflammatory conditions of the human body through the application of electrical energy to the vagus nerve.

IPSCIO Record ID: 4247

License Grant
Licensor of Denmark hereby grants to Licensee a royalty-bearing, non- exclusive, non- transferable, world-wide license under the Licensed Patents to make, have made, use, import, sell or Otherwise Dispose Of Licensed Products.
License Property
Licensed Products shall mean hearing aids, or any apparatus, device or system which is designed for use with a hearing aid, made, used, imported, sold, leased or Otherwise Disposed Of anywhere in the world, by or on behalf of Licensee, which if unlicensed, would directly infringe an apparatus or method claim of a Licensed Patent.

Licensor is the owner of the entire right, title and interest in certain patents and patent applications relating to hearing aids.

     Calibration Device and Auditory Prosthesis

     Having Calibration Information (widin et al)

Country                  Serial                Patent Number

United States            192,213               4,992,966

EPO                      89304712.6            EP 0 341 995 B

Method and Apparatus for Determining Acoustic Parameters of an Auditory
Prosthesis Using Software Model (Widin et al)

Country                  Serial 4              Patent Number

United States            07/888,148            Re 34,961

United States            192,214               4,953,112

Hearing Aid Programming interface (Rising)

Country                  Serial                Patent Number

United States            192,242               4,961,230

Hearing Aid Programming interface and Method (Mangold)

Country                  Serial                Patent Number

United States            192,259               4,989,251

Auditory Prosthesis using Fitting Vectors (Widin)

Country                  Serial #              Patent Number

United States            07/192,351            4,901,353

Auditory Prosthesis With Data logging Capability (Mangold et al)

Country                  Serial                Patent Number

United States            353,220               4,972,487

Method, Apparatus, System and Interface Unit for Programming a Hearing Aid

(Platt)
Country                  Serial                Patent Number

United States            525,901               5,226,086

Hearing Aid and Method For Preparing Same (Woodfill, Jr.)

Country                  Serial                Patent Number

United States            887,592               5,321,757

Auditory Prosthesis, Noise Suppression Apparatus and Feedback Suppression
Apparatus having Focused Adaptive Filtering (Soli et al)

Country                  Serial                Patent Number

United States            912,886               5,402,496

United States            08/317,164

Auditory Prosthesis With User-Controlled Feedback Cancellation (Soli et al)

Country                  Serial 9              Patent Number

United States            07/922,013

United States            08/201,883

United States            08/279,685

Activation and Method For Doing Same (Soli et al)

Country                  Serial #              Patent Number

United States            07/921,508

External Ear Canal Pressure Regulating Device and Tinnitus Suppression Device

(Van den Honert et al)

Country                  Serial 4              Patent Number

United States            359,025               5,024,612

Field of Use
The non-exclusive rights granted apply to the use with a hearing aid.

IPSCIO Record ID: 289542

License Grant
If, and only if, Licensor exercises its option for a license under the CIC Patents pursuant to this agreement, Licensor shall grant (and will cause its Affiliates to grant) to Licensee and its Affiliates the right and option until the expiration of thirty (30) months from the Effective Date or ninety (90) days from the date Licensor exercises its option, whichever is later in time, to obtain a non-exclusive, worldwide, non-transferable, royalty-bearing license under the Savacor Patents.
License Property
Savacor Patents shall mean those patents and patent applications, and all patents and patent applications claiming priority therefrom, that Licensor or its Affiliates acquired from Savacor, Ind. as set forth.  The Savacor Patents shall include the sublicensable patents and patent applications of Cedars Sinai Medical Center listed.

6,970,742 – Method for detecting, diagnosing, and treating cardiovascular disease
6,328,699 – Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure

Field of Use
“CRM Products” means devices for monitoring or electrically stimulating or shocking the heart which are suitable for chronic implantation, in whole or in part, by or with human patients. The term “CRM Products” includes, without limitation cardiac pacemakers, antitachycardia pacemakers, cardiac resynchronization therapy systems, cardioverters, and defibrillators, including combinations thereof; loop recording systems, implantable cardiac monitoring systems, implantable hemodynamic monitoring systems, pulse generators and other waveform generators for such devices; cardiac lead implant catheters and associated tools; leads, electrodes, sensors, capacitors, batteries, power sources, and all other components for such devices; mechanisms for coupling such generators in a stimulating, shocking, sensing, or monitoring relationship to the heart; and data dispensing, processing, and gathering systems for such devices, including programmers, pacing system analyzers, defibrillation system analyzers, testers, encoders, decoders, transtelephonic and other remote monitoring systems and services for use with implantable devices, transmitters, receivers, and computer software-controlled systems, and including the software. The term “CRM Products” excludes, by way of example and not limitation, nerve stimulators (unless used for cardiac therapy), bone growth stimulators, drug release pumps, cardiac pumps, artificial hearts, prosthetic heart valves, catheter ablation devices, imaging systems, catheter location systems, apparatus for revascularization or correction of other physical defects in heart tissue, arrhythmia mapping devices (except as part of an implantable cardiac therapy or monitoring device), angioplasty devices and EKG monitors (other than cardiac stimulation device programmers or other telemetry devices for use with implantable pulse generators or cardiac monitors) which are standalone, non-ambulatory and not intended for transtelephonic or other remote monitoring.

IPSCIO Record ID: 257717

License Grant
The parties are adverse parties following currently pending litigation matters, which are being terminated pursuant to a Settlement Agreement.

The parties are engaged in, inter alia, the design, development, manufacture, and sale of CRM Products.

Pursuant to the Settlement Agreement, the parties have agreed to terminate certain cases and have agreed to enter into a cross licensing of certain rights under the Licensed Patents and Sublicensable Patents.

Licensor grants a non-exclusive, irrevocable, perpetual, worldwide license or sublicense, as the case may be, without the right to sublicense, under all Licensed Patents of Licensor to make, have made, use, sell, have sold, offer to sell, distribute, have distributed, and otherwise dispose of CRM Products, including supplying or causing to be supplied components thereof for use therein, and further including importing CRM Products, including components thereof for use therein, into any jurisdiction where Licensed Patents of Licensor are effective.

Licensor grants the right and option for a period of thirty (30) months from the Effective Date to obtain a non-exclusive, worldwide, non-transferable, royalty-bearing license under the CIC Patents.

License Property
CRM Products means devices for monitoring or electrically stimulating or shocking the heart which are suitable for chronic implantation, in whole or in part, by or with human patients. The term CRM Products includes, without limitation cardiac pacemakers, antitachycardia pacemakers, cardiac resynchronization therapy systems, cardioverters, and defibrillators, including combinations thereof; loop recording systems, implantable cardiac monitoring systems, implantable hemodynamic monitoring systems, pulse generators and other waveform generators for such devices; cardiac lead implant catheters and associated tools; leads, electrodes, sensors, capacitors, batteries, power sources, and all other components for such devices; mechanisms for coupling such generators in a stimulating, shocking, sensing, or monitoring relationship to the heart; and data dispensing, processing, and gathering systems for such devices, including programmers, pacing system analyzers, defibrillation system analyzers, testers, encoders, decoders, transtelephonic and other remote monitoring systems and services for use with implantable devices, transmitters, receivers, and computer software-controlled systems, and including the software.
Field of Use
The field of use is the pacemaker monitoring industry.

IPSCIO Record ID: 257804

License Grant
The parties are adverse parties following currently pending litigation matters, which are being terminated pursuant to a Settlement Agreement.

The parties are engaged in, inter alia, the design, development, manufacture, and sale of CRM Products.

Pursuant to the Settlement Agreement, the parties have agreed to terminate certain cases and have agreed to enter into a cross licensing of certain rights under the Licensed Patents and Sublicensable Patents.

Licensor grants a non-exclusive, irrevocable, perpetual, worldwide license or sublicense, as the case may be, without the right to sublicense, under all Licensed Patents of Licensor to make, have made, use, sell, have sold, offer to sell, distribute, have distributed, and otherwise dispose of CRM Products, including supplying or causing to be supplied components thereof for use therein, and further including importing CRM Products, including components thereof for use therein, into any jurisdiction where Licensed Patents of Licensor are effective.

Licensor shall grant the right and option until the expiration of thirty (30) months from the Effective Date or ninety (90) days from the date Licensor exercises its option, whichever is later in time, to obtain a non-exclusive, worldwide, non-transferable, license under the specific Patents.

License Property
CRM Products means devices for monitoring or electrically stimulating or shocking the heart which are suitable for chronic implantation, in whole or in part, by or with human patients. The term CRM Products includes, without limitation cardiac pacemakers, antitachycardia pacemakers, cardiac resynchronization therapy systems, cardioverters, and defibrillators, including combinations thereof; loop recording systems, implantable cardiac monitoring systems, implantable hemodynamic monitoring systems, pulse generators and other waveform generators for such devices; cardiac lead implant catheters and associated tools; leads, electrodes, sensors, capacitors, batteries, power sources, and all other components for such devices; mechanisms for coupling such generators in a stimulating, shocking, sensing, or monitoring relationship to the heart; and data dispensing, processing, and gathering systems for such devices, including programmers, pacing system analyzers, defibrillation system analyzers, testers, encoders, decoders, transtelephonic and other remote monitoring systems and services for use with implantable devices, transmitters, receivers, and computer software-controlled systems, and including the software.
Field of Use
The field of use is the medical (pacemaker) industry.

IPSCIO Record ID: 4588

License Grant
Pursuant to the licensing agreement, as amended, the University granted a worldwide exclusive license under certain patents and patent applications generally relating to transcutaneous and subcutaneous bilateral neurostimulation for the treatment of neuropsychiatric and neurological disorders. The Licensee is obligated to use commercially reasonable efforts to develop and commercialize one or more licensed products, and thereafter make licensed products reasonably available to the public.
License Property
The license primarily relates to treatments for major neurological and neuropsychiatric disorders such as epilepsy, depression, attention deficit disorder, and post-traumatic stress disorder and to stents.

The present disclosure relates to methods, devices, and systems used for the treatment of mood, anxiety, cognitive, and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, minimally invasive systems, devices and methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.

The present disclosure generally relates to implantable neurostimulator systems, devices and methods of using the same and more particularly relates to implantable neurostimulator systems, devices and methods including at least one implantable electrode for treating neuropsychiatric disorders by stimulating superficial, cutaneous elements of cranial nerve(s).

IPSCIO Record ID: 4834

License Grant
The Licensor granted the Licensee an exclusive world-wide, royalty bearing sublicense in and to the rights to utilize the United States Letters Patent for the use, manufacture and sale of those myoelectric prosthetic devices.
License Property
A myoelectric prosthesis uses electromyography signals or potentials from voluntarily contracted muscles within a person's residual limb on the surface of the skin to control the movements of the prosthesis, such as elbow flexion/extension, wrist supination/pronation (rotation) or hand opening/closing of the fingers. A prosthesis of this type utilizes the residual neuro-muscular system of the human body to control the functions of an electric powered prosthetic hand, wrist or elbow.

The Licensor  is the exclusive licensee or the owner of certain patented and unpatented technology, trade secrets, trademarks and trade names which are utilized by Motion Control in connection with its business of the manufacture and sale of certain prosthetic devices.

IPSCIO Record ID: 3613

License Grant
Licensor, an individual, agrees to grant to Licensee the exclusive worldwide right and license to all of Licensor's rights in and to the Licensed Patents, including but not limited to the exclusive worldwide right and license to make, have made, use, sell, import, export and otherwise dispose of the Licensed Products, and to practice the Licensed Methods.  This will also include the right to grant sublicenses to third parties.
License Property
Licensed Patents are for Treatment of Obesity by Bilateral Vagus Nerve Stimulation.
Field of Use
Licensee is engaged in designing, developing, investigating, testing, and marketing specialized medical devices primarily used or to be used for treating disorders by nervous system stimulation.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.